Larson Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.9K | Buy |
177
+124
| +234% | +$65.1K | ﹤0.01% | 863 |
|
|
2025
Q1 | $33.6K | Sell |
53
-28
| -35% | -$17.8K | ﹤0.01% | 1163 |
|
|
2024
Q4 | $57.7K | Buy |
81
+31
| +62% | +$22.1K | ﹤0.01% | 857 |
|
|
2024
Q3 | $52.6K | Buy |
50
+28
| +127% | +$29.4K | ﹤0.01% | 884 |
|
|
2024
Q2 | $23.1K | Sell |
22
-28
| -56% | -$29.4K | ﹤0.01% | 1010 |
|
|
2024
Q1 | $48.1K | Sell |
50
-13
| -21% | -$12.5K | ﹤0.01% | 698 |
|
|
2023
Q4 | $55.3K | Sell |
63
-9
| -13% | -$7.91K | ﹤0.01% | 625 |
|
|
2023
Q3 | $59.3K | Buy |
72
+59
| +454% | +$48.6K | 0.01% | 567 |
|
|
2023
Q2 | $9.34K | Hold |
13
| – | – | ﹤0.01% | 956 |
|
|
2023
Q1 | $10.7K | Hold |
13
| – | – | ﹤0.01% | 907 |
|
|
2022
Q4 | $9.38K | Hold |
13
| – | – | ﹤0.01% | 877 |
|
|
2022
Q3 | $9K | Hold |
13
| – | – | ﹤0.01% | 823 |
|
|
2022
Q2 | $8K | Sell |
13
-83
| -86% | -$51.1K | ﹤0.01% | 787 |
|
|
2022
Q1 | $67K | Buy |
96
+22
| +30% | +$15.4K | 0.01% | 333 |
|
|
2021
Q4 | $47K | Sell |
74
-38
| -34% | -$24.1K | 0.01% | 394 |
|
|
2021
Q3 | $68K | Hold |
112
| – | – | 0.01% | 249 |
|
|
2021
Q2 | $63K | Buy |
112
+18
| +19% | +$10.1K | 0.01% | 240 |
|
|
2021
Q1 | $44K | Hold |
94
| – | – | 0.01% | 282 |
|
|
2020
Q4 | $45K | Buy |
94
+33
| +54% | +$15.8K | 0.02% | 234 |
|
|
2020
Q3 | $34K | Buy |
+61
| New | +$34K | 0.01% | 251 |
|
|
2020
Q1 | – | Sell |
-15
| Closed | -$6K | – | 636 |
|
|
2019
Q4 | $6K | Hold |
15
| – | – | ﹤0.01% | 355 |
|
|
2019
Q3 | $4K | Hold |
15
| – | – | ﹤0.01% | 387 |
|
|
2019
Q2 | $5K | Hold |
15
| – | – | ﹤0.01% | 318 |
|
|
2019
Q1 | $6K | Hold |
15
| – | – | ﹤0.01% | 277 |
|
|
2018
Q4 | $6K | Buy |
+15
| New | +$6K | 0.01% | 263 |
|